Russian officials have said a second vaccine from Siberia’s state research center, Vector, is not far off.
“Of course, what matters most is that we are able to ensure the unconditional safety of the use of this vaccine and its effectiveness in the future. “I hope this is achieved,” Putin said at a meeting with members of the government on Tuesday, adding that his daughter had been vaccinated with the Gamaleya vaccine.
Kirill Dmitriev, head of the Russian Direct Investment Fund that bankrupted the country̵7;s vaccination effort, said the vaccine would be named “Sputnik”, a reference to the first orbital satellite, which was launched by the Soviet Union and began the vast space of the War. Cold race.
Aggressive strategy by a country eager to declare victory in the midst of one of the worst outbreaks in the world has been criticized by outside scientists who worry that the shootings could be harmful or give people a false sense of security for immunity Theirs. China has already authorized a vaccine for use in its military, ahead of final data that it is safe and effective.
At a congressional hearing this month, Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases testified that it would be problematic if countries would make a vaccine available before extensive testing.
“I hope the Chinese and Russians are actually testing the vaccine before administering the vaccine to anyone, because claims to have a vaccine ready to be distributed before you do the testing, I think is problematic at best,” he said. Fauci.
The leading candidate for Russian vaccines has so far been tested in small, early clinical trials, designed to find the right dose and assess any safety concerns. It was given to the scientists who developed it – in self-experimentation that is unusual in modern science – 50 members of the Russian army and a handful of other volunteers.
Dmitriev said last week Russia would move forward with Phase III for the Gamaleya vaccine once it is registered by the country’s Ministry of Health. In addition to the Russian trial, those parallels will also take place in Saudi Arabia, the United Arab Emirates and possibly Brazil, he said. But while that testing is still ongoing, Russia intends to start vaccinating front-line workers and teachers who will be asked to document how they feel.
“We will have tens of thousands of people already vaccinated like this in August,” Dmitriev said.
The World Health Organization still lists the Gamaleya vaccine as in Phase I. Asked about Russian vaccine developments, WHO spokesman Christian Lindmeier told reporters in Geneva last week that any vaccine must go through “all the tests” and various tests before being licensed to find the strip, “Adding that” between finding or having a clue about possibly having a vaccine that works, and having gone through all the stages, is a big difference. “
The Russian vaccine uses two doses to deliver various harmless cold viruses, or adenoviruses, that are created to carry in the cells the gene for the spicy protein that studies the outside of the coronavirus. The approach is also being used by scientists at pharmaceutical giant Johnson & Johnson, Chinese company CanSino Biologics and Oxford University in their vaccine candidates.
But these other efforts have published data on how vaccines perform in animals ranging from rats to monkeys, and have also provided evidence from early human trials showing the severity of any reaction, ranging from pain at the injection site to in fever. The CanSino vaccine uses one of the same harmless viruses that the Russians are using in its vaccine, and its results have been disappointing to some scientists.
Johnson reported from Washington.